The Business Times
business-time-50

Biotech

Consumer & Healthcare

Chinese biotech overtakes AI as emerging-market growth trade

2026-07-27T03:08:23.000Z
For the Republic, fostering robust and competitive innovation within the healthcare industry is increasingly becoming a national priority as its population ages.
Companies & Markets

Singapore bets on AI in healthcare, but success will depend on commercial sustainability

2026-07-21T08:43:55.000Z
China’s flagship project, the National Biobank, has grown into one of the world’s largest since launching in Shenzhen in 2016 and Beijing is pushing to make it the biggest.
Global Enterprise

China races to build record biobank to rival US drugs research

2026-04-28T04:12:55.000Z
Alps Group's Dr Tham Seng Kong says: "The challenge is no longer about developing technology, but ensuring that it can be used by the mass market. The problem is, most people cannot afford it."
Asean Business

Less than six months after Nasdaq debut, Malaysia’s Alps Group pivots to bridge biotech access gap

2026-04-19T23:00:00.000Z
Gilead will pay US$3.15 billion upfront in cash, and up to US$1.85 billion more if certain milestones are met.
Companies & Markets

Gilead to buy cancer biotech Tubulis in US$5 billion deal

2026-04-07T12:39:41.000Z
Haim Brosh, executive director and CEO at The Trendlines Group, is leading a strategic pivot aimed at streamlining operations.
Companies & Markets
TOPLINE

Now back in the black, SGX-listed Trendlines doubles down on core bets

2026-04-05T23:00:00.000Z
The transactions – the majority of which occurred in the second half of 2025 – relate to prepayments in connection with new projects.
Companies & Markets

US$14.8 million in prepayments to vendors behind Mirxes’ missed 2025 results deadline; independent probe set up

2026-04-03T02:02:38.000Z
For the five trading sessions spanning Mar 13 to 19, institutions were net buyers of Singapore stocks.
Companies & Markets
INSIDE INSIGHTS

Insider and institutional positioning for the week

2026-03-22T06:30:00.000Z
Across Asia, governments have made biotech a strategic priority, enacting policy and ecosystem changes that reduce friction throughout the innovation life cycle.
Opinion & Features

Asia’s biotech moment: From regional strength to global impact

2026-03-20T09:00:00.000Z
The CL1 units use neurons that have been converted from human blood cells.
Startups

Human brain cells run new data centres in Singapore, Melbourne

2026-03-10T00:32:47.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More